KR
Kumaraguru Raja Brookline Capital Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Intensity Therapeutics
INTS
$13.3M
| $0.2832 | $3 |
959%
upside
| Buy |
12 Aug ‘25
28 days ago |
|
2
Palisade Bio
PALI
$5.22M
| $0.5600 | $16 |
2,757%
upside
| Buy |
13 May ‘25
3 months ago |
|
3
Quince Therapeutics
QNCX
$86.5M
| $1.61 | $9 |
459%
upside
| Buy |
18 Dec ‘24
8 months ago |
|
4
SAB Biotherapeutics
SABS
$22.2M
| $2.13 | $8 |
276%
upside
| Buy |
7 Jun ‘24
1 year ago |
|
5
Forte Biosciences
FBRX
$138M
| $11.06 | $100 |
804%
upside
| Buy |
30 May ‘24
1 year ago |
|
|
ADIL
6
Adial Pharmaceuticals
ADIL
$7.64M
| $0.3498 | $150 |
42,782%
upside
| Buy |
11 Jul ‘23
2 years ago |
|
|
GNTA
7
Genenta Science
GNTA
$62.9M
| $3.42 | $15 |
339%
upside
| Buy |
29 Jun ‘23
2 years ago |
|
|
ATYR
8
aTyr Pharma
ATYR
$520M
| $5.31 | $9 |
69%
upside
| Buy |
6 Mar ‘23
2 years ago |
|
9
Monopar Therapeutics
MNPR
$256M
| $44.93 | $90 |
100%
upside
| Buy |
9 Dec ‘22
2 years ago |
|
10
Veru
VERU
$49.4M
| $3.47 | $310 |
8,834%
upside
| Buy |
18 May ‘22
3 years ago |
|
11
Dermata Therapeutics
DRMA
$3.54M
| $5.19 | $33,600 |
647,299%
upside
| Buy |
21 Sep ‘21
4 years ago |
|